| Name | Title | Contact Details |
|---|
Green Tree School and Services (GTSS) is a nonprofit, state-licensed agency that provides education, therapeutic and clinical support to children ages 5-21 with Autism Spectrum Disorder and Severe Emotional Disability. GTSS only serves children whose disabilities are such that they are unable to succeed in a school- based special education program or participate in out of school activities. Rates of both diagnosis are growing, with 1 in 68 children currently affected by Autism and 1 in 78 children affected by Emotional Disability. GTSS’ philosophy is rooted in the belief that every child should have the opportunity to learn the academic, social, emotional, and vocational and life skills they need to achieve resiliency and succeed in their learning, living and working environments. GTSS has worked with children and young adults with special needs since 1957, marking over a half century of Transforming Lives and Impacting Communities. GTSS offers a variety of on-site and off-site services to children with special needs, both directly and through their home school or district. The Approved Private School educates children whose disabilities prevent them from succeeding in a traditional special education program. Specialists work with children, in small groups or individually, to help students meet individual goals. The Outpatient Clinic provides psychiatric evaluation, case management and medication management services to students at the school. Consulting Services, also called Green Tree Partnerships, is an education consulting cooperative created by GTSS. Staff work collaboratively with a school or district and take on the management of portion of that school or district’s special education program. Students who exhibit signs of autism or emotional disabilities, but do not have a complete or up to date Individual Educational Plan, can receive Diagnostic Services from GTSS.
Vetoquinol N.-A. Inc is a Lavaltrie, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health Forum is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.
CheckSite Medical Inc is a Eureka, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.